Brown’s rainy-day plan is the sane solution to California budget crises
Columns, OpinionGov. Jerry Brown may be looking to make the rebalancing of California’s budget the signature achievement of his second administration.
Pharma shakeups put pressure on top brass at Amgen to perform
Columns, OpinionWith activist investor Bill Ackman pushing to buy Botox maker Allegran in a bid with upstart Valeant and restructurings under way at pharma giants GlaxoSmithKline, Eli Lilly & Co. and Novartis, it’s logical to question whether biotech giant Amgen will be next. So far the answer seems to be “not yet” — with one big Read More →
Paso Robles wine pioneer sets out in pursuit of the $100 bottle
Columns, OpinionPaso Robles winemaker Daniel Daou is pursuing the holy grail of California vintners: A cabernet sauvignon or Bordeaux that can reliably fetch $100 a bottle.